Solve.care Trade Signal @alanmasters [SOLVEBTC](260%)
Updated
Solve.care (SOLVEBTC) printed a very strong reversal candle... We can open a trade here.
----
PAIR: Solve.Care | SOLVEBTC
BUY: 0.00001000 - 0.00001150
TARGET:
1) 0.00001330
2) 0.00001640
3) 0.00002050
4) 0.00002510
5) 0.00003050
6) 0.00003450
7) 0.00003900
POTENTIAL PROFITS: 260%
(Buy calculated at 0.00001082)
STOP: Close weekly below 0.00000748.
----
Make sure to do your own research before trading.
This is not financial advice.
Enjoy the profits.
Namaste.
- All the details are marked on the chart just as you can find them below.
- Feel free to leave a comment if you have any questions.
----
PAIR: Solve.Care | SOLVEBTC
BUY: 0.00001000 - 0.00001150
TARGET:
1) 0.00001330
2) 0.00001640
3) 0.00002050
4) 0.00002510
5) 0.00003050
6) 0.00003450
7) 0.00003900
POTENTIAL PROFITS: 260%
(Buy calculated at 0.00001082)
STOP: Close weekly below 0.00000748.
----
Make sure to do your own research before trading.
This is not financial advice.
Enjoy the profits.
Namaste.
Comment
TARGET:1) 0.00001330 |Hit 18-May (+25%)
2) 0.00001640 |Next target...
3) 0.00002050
4) 0.00002510
5) 0.00003050
6) 0.00003450
7) 0.00003900
Trade closed: target reached
TARGET:1) 0.00001330 |Hit 18-May (+25%)
2) 0.00001640 |Hit 19-May (+54%)
3) 0.00002050 |Hit 21-May (+92%)
4) 0.00002510 |Hit 21-May (+136%)
5) 0.00003050 |Hit 21-May (+186%)
6) 0.00003450 |Hit 21-May (+224%)
7) 0.00003900 |Hit 21-May (+266%)
8) 0.00005410 |Hit 21-May (+408%)
9) 0.00006300 |Hit 21-May (+491%)
*) 0.00006500 |Hit 21-May (+510%)/Bittrex
*) 0.00011999 |Hit 21-May (+1027%)/KuCoin
🔝 The Greatest Cryptocurrency Analysis on Earth!
followalan.com
🔥 6-In-1 ULTIMATE Package Offer Now Live! (The Best In The Market)
lamatrades.com (Since 2017)
🚨 The Best Trade-Numbers In The Universe
alansantanatrades.com
followalan.com
🔥 6-In-1 ULTIMATE Package Offer Now Live! (The Best In The Market)
lamatrades.com (Since 2017)
🚨 The Best Trade-Numbers In The Universe
alansantanatrades.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.